Archive
-
Enjoy our most popular Congress-related posts again
With the WFH 2018 World Congress less than a month away, we hope you’re starting to look forward to reconnecting with colleagues and being a...
-
WFH Humanitarian Aid Program continues to make significant progress in providing sustainable treatment globally
For many people with hemophilia around the world, access to care and treatment can be a considerable daily challenge. Through the expanded WFH Humanitarian Aid...
-
Now available: proceedings of the 10th WFH Global Forum
The Proceedings of the 10th WFH Global Forum on Research and Treatment Products for Bleeding Disorders are now available online. The 10th WFH Global Forum—held...
-
Browsing and finding WFH resources on the eLearning Platform
The World Federation of Hemophilia (WFH) is pleased to showcase its large library of educational resources developed to meet the needs of national member organizations...
-
Speaker profile: Nathalie Roussel
The WFH 2018 World Congress will feature speakers who will discuss important—and cutting edge—topics facing the bleeding disorders community today. In the lead-up to Congress,...
-
Q&A with WFH leaders – Cesar Garrido, Lay Member
Over the next several months, Alain Baumann will be hosting a series of Questions & Answer sessions with World Federation of Hemophilia (WFH) leaders. Today...
-
Sharing knowledge on World Hemophilia Day 2018
Every year World Hemophilia Day features a different theme. This year’s theme is Sharing Knowledge Makes us Stronger, and on April 17, the World Federation...
-
Update from Roche on Hemlibra (emicizumab)
Update from Roche on Hemlibra (emicizumab), for more information please click here.
-
Diagnosis of von Willebrand Disease: Two New Resources Clarify Complexity
The accurate diagnosis of von Willebrand disease (VWD) is crucial to its management. Therefore, the World Federation of Hemophlia (WFH) is pleased to announce the...
-
Update on Shire and Roche/Genentech patent dispute regarding Hemlibra
Update: On March 28, 2018, Chugai Pharmaceuticals, a subsidiary of Roche, announced that a Japanese court ruled that the hemophilia treatment product Hemlibra (emicizumab) does...
-
Five von Willebrand Disease Outreach Programs: Secrets to Success
At the World Federation of Hemophilia (WFH) World Congress in Orlando, U.S.A, Andra James (U.S.A.) chaired a discussion between Amy Griffith (Canada), Peter Noun (Lebanon),...
-
The global bleeding disorders community @ Glasgow, Scotland
The World Federation of Hemophilia’s (WFH) 2018 World Congress is the largest international meeting for the global bleeding disorders community, with sessions and talks that...
